Park, S. J., Najmi, O., Chang, J., Tan, T., Vaidya, P., Chow, W. A., Daud, A., Daniels, G. A., Boffo, S. (2026). A phase 2 study of neoadjuvant nivolumab + relatlimab versus nivolumab in patients with resectable high-risk basal cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9613